Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus

EMBO Journal

Volumn 17, Issue 1, 1998, Pages 61-70

  Müller, Stefan ^a   Matunis, Michael J ^b   Dejean, Anne ^a  

^a INSTITUT PASTEUR   (France)

^b NONE

Author keywords

Arsenic; Nuclear bodies; PML; Post translational modification; SUMO 1

Indexed keywords

ARSENIC TRIOXIDE; CELL PROTEIN; UBIQUITIN;

ARTICLE; CELL NUCLEUS; CELL NUCLEUS INCLUSION BODY; CONJUGATION; CONTROLLED STUDY; COVALENT BOND; DRUG EFFECT; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION;

ARSENICALS; CELL NUCLEUS; HELA CELLS; HUMANS; MOLECULAR WEIGHT; NEOPLASM PROTEINS; NUCLEAR PROTEINS; OXIDES; PHOSPHORYLATION; SUMO-1 PROTEIN; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; UBIQUITINS;

EID: 0037498052     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/17.1.61     Document Type: Article

References (48)

1. Ali, S., Lutz, Y., Bellocq, J.P., Chenard-Neu, M.P., Rouyer, N. and Metzger, D. (1993) Production and characterization of monoclonal antibodies recognising defined regions of the human oestrogen receptor. Hybridoma, 12, 391-405.
2. Baek, S.H., Woo, S.K., Lee, J.L. Yoo, Y.J., Cho, C.M., Kang, M.S., Tanaka, K. and Chung, C.H. (1997) New de-ubiquitinating enzyme, ubiquitin C-terminal hydrolase 8, in chick skeletal muscle. Biochem. J., 325, 325-330.
3. Boddy, M.N., Howe, K., Etkin, L.D., Solomon, E. and Freemont, P.S. (1996) PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia. Oncogene, 13, 971-982.
4. Brown, M.T., Goetsch, L. and Hartwell, L.H. (1993) MIF2 is required for mitotic spindle integrity during anaphase spindle elongation in Saccharomyces cerevisiae. J. Cell Biol., 123, 387-402.
5. Carvalho, T., Seeler, J.S., Ohman, K., Jordan, P., Pettersson, U., Akusjarvi, G., Carmo-Fonseca, M. and Dejean, A. (1995) Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies. J. Cell Biol., 131, 45-56.
6. Castaigne, S., Chomienne, C., Daniel, M., Ballerini, P., Berger, R., Fenaux, P. and Degos, L. (1990) All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. (I) Clinical results. Blood, 76, 1704-1709.
7. Chang, K.S., Fan, Y.H., Andreeff, M., Liu, J. and Mu, Z.M. (1995) The PML gene encodes a phosphoprotein associated with the nuclear matrix. Blood, 85, 3646-3653.
8. 3 induces NB4 cell apoptosis with downregulation of Bcl-2 expression and modulation of PML-RAR alpha/PML proteins. Blood, 88, 1052-1061.
9. Ciechanover, A. (1994) The ubiquitin-proteasome proteolytic pathway. Cell, 79, 13-21.
10. de Thé, H., Lavau, C., Marchio, A., Chomienne, C., Degos, L. and Dejean, A. (1991) The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell, 66, 675-684.
11. Deshaies, R.J. (1997) Phosphorylation and proteolysis: partners in the regulation of cell division in budding yeast. Curr. Opin. Genet. Dev., 7, 7-16.
12. Doucas, V., Ishov, A.M., Romo, A., Juguilon, H., Weitzman, M.D., Evans, R.M. and Maul, G.G. (1996) Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure. Genes Dev., 10, 196-207.
13. Dyck, J.A., Maul, G.G., Miller, W.H., Chen, J.D., Kakizuka, A. and Evans, R.M. (1994) A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell, 76, 333-343.
14. Everett, R.D. and Maul, G.G. (1994) HSV-1 IE protein Vmw110 causes redistribution of PML. EMBO J., 13, 5062-5069.
15. Everett, R., O'Hare, P., O'Rourke, D., Barlow, P. and Orr, A. (1995) Point mutations in the herpes simplex virus type 1 Vmw110 RING finger helix affect activation of gene expression, viral growth, and interaction with PML-containing nuclear structures. J. Virol., 69, 7339-7344.
16. Everett, R.D., Meredith, M., Orr, A., Cross, A., Kathoria, M. and Parkinson, J. (1997) A novel ubiquitin-specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein. EMBO J., 16, 1519-1530.
17. Gaub, M.-P., Rochette-Egly, C., Lutz, Y., Ali, S., Matthes, H., Scheuer, I. and Chambon, P. (1992) Immunodetection of multiple species of retinoic acid receptor alpha: evidence for phosphorylation. Exp. Cell Res., 201, 335-346.
18. Goddard, A.D., Borrow, J., Freemont, P.S. and Solomon, E. (1991) Characterization of a zinc finger gene disrupted by the t(15;17) in acute promyelocytic leukemia. Science, 254, 1371-1374.
19. Guldner, H.H., Szostecki, C., Grötzinger, T. and Will, H. (1992) IFN enhances expression of Sp100, an autoantigen in primary biliary cirrhosis. J. Immunol., 149, 4067-4073.
20. Hochstrasser, M. (1995) Ubiquitin, proteasomes, and the regulation of intracellular protein degradation. Curr. Opin. Cell Biol., 7, 215-223.
21. Hochstrasser, M. (1996) Protein degradation or regulation: Ub the judge. Cell, 84, 813-815.
22. Huang, M.E., Ye, Y.C., Chen, S.R., Chai, J.R., Lu, J.X., Zhao, L., Gu, L.J. and Wang, Z.Y. (1988) Use of all trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood, 72, 567-571.
23. Kakizuka, A., Miller, W.H., Umesono, K., Warrell, R.P., Frankel, S.R., Murty, V.V.V.S., Dmitrovsky, E. and Evans, R.M. (1991) Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARa with a novel putative transcription factor, PML. Cell, 66, 663-674.
24. Kastner, P., Perez, A., Lutz, Y., Rochette-Egly, C., Gaub, M.P., Durand, B., Lanotte, M., Berger, R. and Chambon, P. (1992) Structure, localization and transcriptional properties of two classes of retinoic acid receptor a fusion proteins in acute promyelocytic leukemia (APL): structural similarities with a new family of oncoproteins. EMBO J., 11, 629-642.
25. Kelly, C., van Driel, R. and Wilkinson, G.W.G. (1995) Disruption of PML-associated nuclear bodies during human cytomegalovirus infection. J. Gen. Virol., 76, 2887-2893.
26. Koken, M.H.M. et al. (1994) The t(15;17) translocation alters a nuclear body in a retinoic acid-reversible fashion. EMBO J., 13, 1073-1083.
27. Korioth, F., Gieffers, C., Maul, G.G. and Frey, J. (1995) Molecular characterization of NDP52, a novel protein of the nuclear domain 10, which is redistributed upon virus infection and interferon treatment. J. Cell Biol., 130, 1-13.
28. Lanotte, M., Martin-Thouvenin, V., Najman, S., Balerini, P., Valenzi, F. and Berger, R. (1991) NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acyte promyelocytic leukemia (M3). Blood, 77, 1080-1086.
29. Lapenta, V., Chiurazzi, P., van der Spek, P., Pizzuti, A., Hanaoka, F. and Brahe, C. (1997) SMT3A, a human homologue of the S.cerevisiae SMT3 gene, maps to chromosome 21qter and defines a novel gene family. Genomics, 40, 362-366.
30. Lavau, C. et al. (1995) The acute-promyelocytic leukaemia-associated PML gene is induced by interferon. Oncogene, 11, 871-876.
31. Mahajan, R., Delphin, C., Guan, T., Gerace, L. and Melchior, F. (1997) A small ubiquitin-related polypeptide involved in targeting RanGAP1 to nuclear pore complex protein RanBP2. Cell, 88, 97-107.
32. Mannen, H., Tseng, H.M., Cho, C.L. and Li, S.S. (1996) Cloning and expression of human homolog HSMT3 to yeast SMT3 suppressor of MIF2 mutations in a centromere protein gene. Biochem. Biophys. Res. Commun., 222, 178-180.
33. Matunis, M.J., Coutavas, E. and Blobel, G. (1996) A novel ubiquitin-like modification modulates the partitioning of the Ran-GTPase-activating protein RanGAP1 between the cytosol and the nuclear pore complex. J. Cell Biol., 135, 1457-1470.
34. Maul, G.G., Guldner, H.H. and Spivack, J.G. (1993) Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product (ICP0). J. Gen. Virol., 74, 2679-2690.
35. Meluh, P.B. and Koshland, D. (1995) Evidence that the MIF2 gene of Saccharomyces cerevisiae encodes a centromere protein with homology to the mammalian centromere protein CENP-C. Mol. Biol. Cell, 6, 793-807.
36. Okura, T., Gong, L., Kamitani, T., Wada, T., Okura, I., Wei, C.F., Chang, H.M. and Yeh, E.T. (1996) Protection against Fas/AP0-1-and tumor necrosis factor-mediated cell death by a novel protein, sentrin. J. Immunol., 15, 4277-4281.
37. Pandolfi, P.P., Grignani, F., Alcalay, M., Mencarelli, A., Biondi, A., Lo Coco, F., Grignani, K and Pelicci, P.G. (1991) Structure and origin of the acute promyelocytic leukemia myl/RARα cDNA and characterization of its retinoid-binding and transactivation properties. Oncogene, 6, 1285-1292.
38. Reddy, B.A., Etkin, L.D. and Freemont, P.S. (1992) A novel zinc finger coiled-coil domain in a family of nuclear proteins. Trends Biochem. Sci., 17, 344-345.
39. Saitoh, H., Pu, R., Cavenagh, M. and Dasso, M. (1997) RanBP2 associates with Ubc9p and a modified form of RanGAP1. Proc. Natl Acad. Sci. USA, 94, 3736-3741.
40. Seufert, W., Futcher, B. and Jentsch, S. (1995) Role of a ubiquitin-conjugating enzyme in degradation of S-and M-phase cyclins. Nature, 373, 78-81.
41. Shen, Z., Pardington-Purtymun, P.E., Comeaux, J.C., Moyzis, R.K. and Chen, D.J. (1996) UBL1, a human ubiquitin-like protein associating with human RAD51/RAD52 proteins. Genomics, 36, 271-279.
42. Stadler, M. et al. (1995) Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element. Oncogene, 11, 2565-2573.
43. Sternsdorf, T., Guldner, H., Szostecki, C., Grotzinger, T. and Will, H. (1995) Two nuclear dot-associated proteins, PML and Sp100, are often co-autoimmunogenic in patients with primary biliary cirrhosis. Scand. J. Immunol., 42, 257-268.
44. Szostecki, C., Guldner, H.H., Netter, H.J. and Will, H. (1990) Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis. J. Immunol., 145, 4338-4347.
45. Treier, M., Staszewski, L.M. and Bohmann, D. (1994) Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell, 78, 787-798.
46. Weis, K., Rambaud, S., Lavau, C., Jansen, J., Carvalho, T., Carmo-Fonseca, M., Lamond, A. and Dejean, A. (1994) Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic leukemia cells. Cell, 76, 345-356.
47. Yoshida, H., Kitamura, K., Tanaka, K., Omura, S., Miyazaki, T., Hachiya, T., Ohno, R. and Naoe, T. (1996) Accelerated degradation of PML-retinoic acid receptor alpha (PML-RARA) oncoprotein by all-trans-retinoic acid in acute promyelocytic leukemia: possible role of the proteasome pathway. Cancer Res., 56, 2945-2948.
48. Zhu, J., Koken, M.H., Quignon, F., Chelbi-Alix, M.K., Degos, L., Wang, Z.Y., Chen, Z. and de Thé, H. (1997) Arsenic-induced PML targeting onto nuclear bodies: implications for the treatment of acute promyelocytic leukemia. Proc. Natl Acad. Sci. USA, 94, 3978-3983.